EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ESR Essentials: MRI-based T-staging in prostate cancer—practice recommendations by the European Society of Urogenital Radiology

Georgios Agrotis, Fredrik Jäderling, Amish Lakhani, Ana Sofia L Moreira, Maka Kekelidze, Justyna Rembak-Szynkiewicz, Vibeke Logager, Harriet Thoeny, Geert Villeirs, Sungmin Woo, Ivo G Schoots

European Radiology · 2026

DOI: 10.1007/s00330-026-12397-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Radiology, 2026. Verfasst von Georgios Agrotis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.agrotis@nki.nl. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Prostatic Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MRI-based T-staging in prostate cancer enables more precise and individualised treatment decisions compared with traditional clinical T-staging, yet inconsistent image acquisition, interpretation, and terminology limit reproducibility and clinical integration. This report recommends standardising MRI-based T-staging to strengthen its prognostic and therapeutic relevance. The prefix “mr” for MRI-based T-staging should be used, together with “extraprostatic extension” as the official radiologic term, replacing “extracapsular extension”, to ensure consistency with pathology and the UICC TNM system. Within mrT3a disease, radiologists should differentiate “focal” from “established” extraprostatic extension, as established disease carries a higher recurrence risk and often requires more extensive surgical or radiotherapeutic management. Quality assurance programs, standardised acquisition protocols, and targeted education for radiologists and technologists are essential for improving interinstitutional consistency. Clinicians should incorporate proposed terminology and focal/established subclassification into structured reports and multidisciplinary discussions to refine risk stratification and guide nerve-sparing surgery or adjuvant therapy decisions. These coordinated measures will enhance the reproducibility and prognostic value of MRI-based T-staging, reduce overtreatment, and improve patient outcomes in contemporary prostate cancer management. Key Points The prefix “mr” should be added to T-staging for reporting and multidisciplinary team guidance, distinguishing it from clinical and pathological T-staging; extraprostatic extension should be explicitly defined as mrT3a. Staging assessment should be refined by subclassifying focal versus established extraprostatic extension to better guide risk stratification and treatment decisions. More reproducible and objective criteria of MRI-derived parameters should be adopted to reduce interpretation variability and to improve reader reproducibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingProstatic NeoplasmsHumansMaleEuropeNeoplasm StagingPrognosisRadiologyReproducibility of ResultsSocieties, Medical

Stichwörter der Autor:innen

Extraprostatic extensionMagnetic resonance imagingNeoplasm stagingPrognosisProstate cancer

Autor:innen und Institutionen

  • Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.agrotis@nki.nl.
  • GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. g.agrotis@nki.nl.
  • Department of Radiology, Capio St Göran's Hospital, Stockholm, Sweden.
  • Institution of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Stockholm, Sweden.
  • Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London, UK.
  • Department of Imaging, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.

Zitieren

APA

Agrotis, G., Jäderling, F., Lakhani, A., Moreira, A. S. L., Kekelidze, M., Rembak-Szynkiewicz, J., Logager, V., Thoeny, H., Villeirs, G., Woo, S., & Schoots, I. G. (2026). ESR Essentials: MRI-based T-staging in prostate cancer—practice recommendations by the European Society of Urogenital Radiology. European Radiology. https://doi.org/10.1007/s00330-026-12397-8

Vancouver

Agrotis G, Jäderling F, Lakhani A, Moreira ASL, Kekelidze M, Rembak-Szynkiewicz J, et al. ESR Essentials: MRI-based T-staging in prostate cancer—practice recommendations by the European Society of Urogenital Radiology. European Radiology. 2026. doi:10.1007/s00330-026-12397-8

BibTeX
@article{Agrotis2026,
  author = {Agrotis, Georgios and Jäderling, Fredrik and Lakhani, Amish and Moreira, Ana Sofia L and Kekelidze, Maka and Rembak-Szynkiewicz, Justyna and Logager, Vibeke and Thoeny, Harriet and Villeirs, Geert and Woo, Sungmin and Schoots, Ivo G},
  title = {ESR Essentials: MRI-based T-staging in prostate cancer—practice recommendations by the European Society of Urogenital Radiology},
  journal = {European Radiology},
  year = {2026},
  doi = {10.1007/s00330-026-12397-8}
}
Kostenlos starten →